A Full-Arch Implant- Supported Prosthesis in the Upper and/or Lower Jaw-USA (NCT03655990) | Clinical Trial Compass
TerminatedNot Applicable
A Full-Arch Implant- Supported Prosthesis in the Upper and/or Lower Jaw-USA
Stopped: Impact of COVID-19 on Recruitment
United States10 participantsStarted 2018-08-07
Plain-language summary
This study follows subjects who have agreed with their dentist that their failing teeth or missing teeth all need replacing. This study follows their standard routine care with some additional assessments. The dental treatment option that replaces a whole arch or both arches (upper and lower jaws) of the mouth is call "Teeth in a Day" and information on the use of the JUVORA™ Dental Disc during this treatment is what is being collected as part of this study along with subjects follow-up care.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subjects aged 18 years or older in need of a full-arch implant supported rehabilitation in a single jaw (mandibular or maxillary) or both edentulous jaws (mandibular and maxillary).
* Subjects with adequate bone quality and quantity to allow the placement of a minimum of four Neodent implants into the arch area.
* Subjects who, in the opinion of the Investigator, are able to understand this clinical study, co-operate with the procedures and are willing to return to the clinic for all the required post-operative follow-ups.
* Subjects who are able to give voluntary, written informed consent to participate in this clinical study and from whom consent has been obtained.
Exclusion Criteria:
Female subjects who are pregnant or lactating.
* Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes.
* Subjects with any condition that would compromise their participation and follow-up in this clinical study.
* Subjects with insufficient bone volume or quality in the edentulous jaw.
* Subjects on any chemotherapeutic or bisphosphonate medications.
* Subjects with evidence of tumour and/or malignant disease with resultant life expectancy of less than 2 years.
* Subjects who smoke more than 10 cigarettes per day.
* Subjects who are currently enrolled in another clinical study.